Full Name
BUYSE, Marc
Email
marc.buyse@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Refined By:
Date Issued:  [2000 TO 2009]
Type:  Journal Contribution

Results 21-40 of 55 (Search time: 0.008 seconds).

Issue DateTitleContributor(s)TypeCat.
212006Surrogate threshold effect: An alternative measure for meta-analytic surrogate endpoint validationBURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
222006A unifying approach for surrogate marker validation based on Prentice's criteriaALONSO ABAD, Ariel; MOLENBERGHS, Geert; GEYS, Helena; BUYSE, Marc; VANGENEUGDEN, TonyJournal ContributionA1
232005A quantitative study of tumor response and progression-free survival as surrogate endpoints for overall survival in first-line treatment of metastatic breast cancerBURZYKOWSKI, Tomasz; Piccart, MJ; Sledge, G; Carmichael, J; Luck, HJ; Mackey, John R.; Nabholtz, JM; Paridaens, R; Biganzoli, L; Jassem, J; Blohmer, JU; Bontenbal, M; Bonneterre, J; Chan, S; Atalay, G.; Therasse, P; BUYSE, MarcJournal ContributionM
242005Effects of taxanes alone or in combination with anthracyclines on tumor response, progression-free survival and overall survival in first-line chemotherapy of patients with metastatic breast cancer: an analysis of 4,256 patients randomized in 12 trialsPiccart, MJ; BURZYKOWSKI, Tomasz; Sledge, G; Luck, HJ; Mackey, John R.; Nabholtz, JM; Paridaens, R; Biganzoli, L; Jassem, J; Blohmer, JU; Bontenbal, M; Bonneterre, J; Chan, S; Atalay, G.; Carmichael, J; BUYSE, Marc; Therasse, PJournal ContributionM
252005Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 tandomized trialsSargent, Daniel J.; Wieand, Harry S.; Haller, Daniel G.; Gray, Richard; Benedetti, Jacqueline; BUYSE, Marc; Labianca, Roberto; Seitz, Jean Francois; O'Callaghan, Christopher J.; Francini, Guido; Grothey, Axel; O'Connell, Michael; Catalano, Paul J.; Blanke, Charles D.; Kerr, David; Green, Erin; Wolmark, Norman; André, Thierry; Goldberg, Richard M.; De Gramont, AimeryJournal ContributionA1
262005Progression-free survival (PFS) as a surrogate for overall survival (OS) in patients with advanced colorectal cancer: An analysis of 3159 patients randomized in 11 trials.BUYSE, Marc; BURZYKOWSKI, Tomasz; Carroll, K; Michiels, Stefan; Pignon, JP; Piedbois, PJournal ContributionM
272004Prentice's approach and the meta-analytic paradigm: a reflection on the role of statistics in the evaluation of surrogate endpointsALONSO ABAD, Ariel; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; RENARD, Didier; GEYS, Helena; SHKEDY, Ziv; TIBALDI, Fabian; CORTINAS ABRAHANTES, Jose; BUYSE, MarcJournal ContributionA1
282004A perspective on surrogate endpoints in controlled clinical trialsMOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; ALONSO ABAD, Ariel; BUYSE, MarcJournal ContributionA1
292004Efficacy of oral adjuvant therapy after resection of colorectal cancer: 5-year results from three randomized trialsSakamoto, J.; Ohashi, Y.; Hamada, C.; BUYSE, Marc; BURZYKOWSKI, Tomasz; Piedbois, P.Journal ContributionA1
302004FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR studyTournigand, Christophe; André, Thierry; Achille, Emmanuel; Lledo, Gérard; Flesh, Michel; Mery-Mignard, Dominique; Quinaux, Emmanuel; Couteau, Corinne; BUYSE, Marc; Ganem, Gérard; Landi, Bruno; Colin, Philippe; Louvet, Christophe; de Gramont, AimeryJournal ContributionA1
312004Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysisBUYSE, Marc; et alJournal ContributionA1
322004The validation of surrogate endpoints by using data from randomized clinical trials: a case-study in advanced colorectal cancerBURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; BUYSE, MarcJournal ContributionA1
332003Overall survival is not a realistic endpoint for clinical trials in advanced solid tumors: a critical assessment based on recently reported phase III trials in colorectal and breast cancerDi Leo, A.; Bleiberg, H.; BUYSE, MarcJournal ContributionA1
342003Comparaison entre LV5FU2 bi-mensuel et FUFOL mensuel pendant 24 ou 36 semaines en traitement adjuvant des cancers du colon stade II et III: résultats à 4 ans d'une étude randomiséeBUYSE, Marc; André, Thierry; Artru, P.; Gamelin, E.; Bouche, O.; Achille, Emmanuel; Piedbois, P.; Flesch, M.; Tubiana-Mathieu, N.; de Gramont, A.Journal ContributionA2
352003Simplified hierarchical linear models for the evaluation of surrogate endpointsTIBALDI, Fabian; CORTINAS ABRAHANTES, Jose; MOLENBERGHS, Geert; RENARD, Didier; BURZYKOWSKI, Tomasz; BUYSE, Marc; Parmar, Mahesh; Stijnen, Theo; Wolfinger, RussJournal ContributionA1
362003Using the 'expected' survival to explain differences between the results of randomized trials: a case in advanced ovarian cancerBUYSE, Marc; BURZYKOWSKI, Tomasz; Parmar, Mahesh; Torri, Valter; Omura, George; Colombo, Nicoletta; Williams, Chris; Conte, Pierfranco; Vermorken, JanJournal ContributionA1
372003Validation of a longitudinally measured surrogate for a time-to-event endpointRENARD, Didier; GEYS, Helena; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; BUYSE, Marc; VANGENEUGDEN, Tony; BIJNENS, LucJournal ContributionA1
382003Semimonthly Versus Monthly Regimen of Fluorouracil and Leucovorin Administered for 24 or 36 Weeks as Adjuvant Therapy in Stage II and III Colon Cancer: Results of a Randomized TrialBUYSE, Marc; André, Thierry; Colin, P.; Liouvet, C.; Gamelin, E.; Bouche, O.; Achille, Emmanuel; Colbert, N.; Boaziz, C.; Piedbois, P.; Tubiana-Mathieu, N.; Boutan-Laroze, A.; Flesch, M.; Billau, V.; de Gramont, A.Journal ContributionA1
392002Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early cancer: first results of the ATAC randomized trialBUYSE, MarcJournal ContributionA1
402002Statistical challenges in the evaluation of surrogate endpoints in randomized trialsMOLENBERGHS, Geert; BUYSE, Marc; GEYS, Helena; RENARD, Didier; BURZYKOWSKI, Tomasz; ALONSO ABAD, ArielJournal ContributionA1